Medicine & TechnologyA new vaccine for deadly brain cancer triggers fierce immune response to attack an aggressive type of brain tumor in a first-ever human clinical trial. Check this article to learn more.
The personalized cancer vaccine uses similar technology to the COVID-19 vaccine of Oxford-AstraZeneca to train the immune system for cancer cells. Check out how promising the critical trial results are.